9 results
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Platelet Aggregation Inhibitors ... #AntiPlatelet ... #Inhibitors #Pharmacology ... #Table #Overview ... #Cardiology
Lisinopril - ACE inhibitor used for the treatment of hypertension and heart failure. 3rd most prescribed
Lisinopril - ACE ... inhibitor used ... #Pharmacology #Lisinopril ... AngiotensinConvertingEnzyme #Inhibitor ... #Overview #Review
Heart Failure Medications Summary
Inhibitors of the Renin-Angiotensin System:
 • ACE Inhibitors: Benazepril, Captopril, Enalapril, Lisinopril, Quinapril,
Medications Summary Inhibitors ... Renin-Angiotensin System: • ACE ... Inhibitors: Benazepril ... Spironolactone Neprilysin Inhibitor ... #pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Angiotensin-Converting Enzyme Inhibitors ... to hypertension Antiplatelets ... Monoamine Oxidase Inhibitors ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
- P2Y12 Inhibitor ... • Irreversible inhibitor ... • Reversible inhibitor ... Conversion #P2Y12 #Inhibitor ... #Switching #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Between Oral P2Y12 Inhibitors ... administration of a loading ... .117.031164 #P2Y12 #Inhibitor ... ticagrelor #prasugrel #pharmacology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
endomyocardial biopsy Pharmacology ... : • ACE Inhibitors ... receptor-neprilysin inhibitors ... diagnosis #management #cardiology ... #pharmacology #
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
(or equivalent antiplatelet ... ACE inhibitor: consider ... ARB: if ACE inhibitor ... inhibitor/ARB + ... Management #Algorithm #cardiology
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
Cangrelor - Pharmacology ... an oral P2Y12 inhibitor ... artery bypass grafting ... CABG) - As antiplatelet ... from IV to PO Antiplatelet